The granting of a licence to cultivate indigenous fungi containing psilocybin, the active compound found in psychedelic mushrooms, is the first of its kind in New Zealand and a major milestone in a Māori health science collaboration led by Rangiwaho Marae, based south of Gisborne.
A medicinal cannabis company says illogical legislation has stopped it supplying product for New Zealand patients and it's exporting its East Coast strains around the world instead.